#None #gene therapy #Xtalks #viral vector

Overcoming Challenges in Viral Vector Manufacturing

In recent years, gene therapy has emerged as a groundbreaking solution in modern medicine. It promises not only transformative treatments but also the potential for permanent cures across a variety of medical conditions. Despite the optimism surrounding this innovative approach, the industry faces substantial obstacles in scaling viral vector manufacturing to meet the surging commercial demand.

In a free webinar hosted by Xtalks, participants will delve into the intricacies of viral vector production, examining the critical challenges that impede the efficient scaling of this essential component in gene therapies.

Focus of the Webinar

The webinar will shed light on the bottlenecks affecting viral vector manufacturing, encompassing both upstream and downstream processes. Attendees will have the opportunity to gain practical insights aimed at improving scalability, which is crucial for the successful commercialization of gene therapies. Additionally, industry leaders will discuss overarching challenges, such as high production costs, shifting regulatory landscapes, and the multifaceted nature of technology transfers that impact the viability of these therapies.

A significant element of this discussion will be two case studies that present real-world scenarios of viral vector scale-up. The first case will examine the production challenges faced when scaling AAV (Adeno-Associated Virus) up to a capacity of 2,000 liters. The second case focuses on the implementation of a platform approach to streamline scale-up activities. Both cases illustrate effective strategies to enhance process robustness, improve yield efficiency, and ultimately lower manufacturing costs.

What to Expect

Attendees will leave the webinar equipped with valuable knowledge on how to navigate the complexities of viral vector scaling. Insights shared by leading experts, including Emigdio Reyes, PhD, Director of Upstream Process Development at FUJIFILM Biotechnologies, will provide not only theoretical frameworks but also actionable strategies that can be employed in real-world applications. This discussion is poised to empower participants to advance their understanding of Manufacturing Challenges while also engaging in a question-and-answer segment with the experts.

Participants will also have the chance to connect with industry peers, fostering an environment of collaboration and knowledge-sharing as they explore potential solutions together. The focus will be on addressing the pressing need for effective manufacturing methods to ensure the accessibility of gene therapies for patients worldwide.

Don't Miss Out

By joining this webinar, you will be at the forefront of discussions that have the potential to shape the future of gene therapy manufacturing. With rapid advancements in the field, staying informed is vital to navigating its complexities successfully.

Mark your calendar for Wednesday, June 10, 2026, at 11 AM EDT (5 PM CEST). For further information and registration, visit the Xtalks website. This is an opportunity you cannot afford to miss as we work towards overcoming the challenges in viral vector manufacturing, enhancing the delivery of clinical solutions to those in need.

Xtalks remains committed to supporting professionals across the medical and biotechnological sectors. Engage with us to explore the trends and advancements that are moving the industry forward.

For inquiries regarding hosting your own webinar or collaborating with Xtalks, please visit our partnership page. We look forward to seeing you at the webinar and hope to contribute to your continual growth in this rapidly evolving sector.